Pagoclone (CAS 133737-32-3) Anxiolytic API

Pagoclone (CAS 133737-32-3) is a high-quality anxiolytic API, classified as a selective gamma-aminobutyric acid (GABA) A receptor modulator. Presenting as a white to pale yellow crystalline powder, it is manufactured under strict GMP standards to ensure ≥99% purity and superior molecular stability, delivering consistent bioactivity in pharmaceutical formulations. By selectively targeting GABA A receptors, it enhances inhibitory neurotransmission in the brain, effectively alleviating anxiety symptoms without significant sedative side effects.

This pharmaceutical-grade API adheres to global pharmacopoeia requirements (USP/EP/BP), making it ideal for pharmaceutical manufacturers, biotech firms, and neuropharmacology research institutions. It offers reliable batch-to-batch consistency, excellent formulation compatibility, and clinically validated efficacy. For those seeking a targeted, low-side-effect raw material to develop anxiolytic therapeutics, Pagoclone stands out as a